Researcher
An Coosemans
- Disciplines:Cancer therapy, Cancer biology, Neurosurgery
Affiliations
- Laboratory for Tumor Immunology and Immunotherapy (Division)
Responsible
From1 Oct 2019 → Today - Laboratory for Tumor Immunology and Immunotherapy (Division)
Member
From1 Sep 2016 → Today - Gynaecological Oncology (Division)
Member
From1 Oct 2013 → 31 Aug 2016 - Allergy and Clinical Immunology Research Group (Division)
Member
From1 Oct 2012 → 30 Sep 2013
Projects
1 - 10 of 18
- Development of tumor-derived dendritic cell therapies to prevent ovarian cancer metastasisFrom13 Nov 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- How to deal with recurrent ovarian cancer: a new approach.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Developing combinatorial immunotherapy for glioblastomaFrom7 Nov 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Next-generation, multi-technology immune-monitoring and easy-access spectral flow cytometryFrom1 May 2022 → TodayFunding: FWO Medium Size Research Infrastructure
- DIPITO: valorisation of deep immune profiling and novel immunotherapeutics for oncology.From1 Oct 2021 → TodayFunding: IOF - mandates
- Preclinical evaluation of novel radionuclide therapies in different cancer modelsFrom8 Jul 2021 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccines.From1 Jan 2021 → TodayFunding: FWO research project (including WEAVE projects)
- Spectral flowcytometry (Cytek Aurora)From1 Jan 2021 → 31 Dec 2022Funding: BOF - scientific equipment program
- Deciphering the dendritic cell compartment in ovarian cancer to assess their potential as tumor vaccinesFrom8 Oct 2020 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Rational approach for immunotherapy in ovarian cancer.From1 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
Publications
31 - 40 of 110
- Validation of models to diagnose ovarian cancer in patients managed surgically or conservatively: multicentre cohort study(2020)
Authors: Ben Van Calster, Wouter Froyman, Jolien Ceusters, Laure Wynants, An Coosemans, Ignace Vergote, Tom Bourne, Dirk Timmerman
- Simultaneous in vivo PET/MRI using fluorine-18 labeled Fe3O4@Al(OH)3 nanoparticles: comparison of nanoparticle and nanoparticle-labeled stem cell distribution(2020)
Authors: Sarah Belderbos, Frederik Cleeren, Christophe Deroose, An Coosemans, Willy Gsell, Guy Bormans, Uwe Himmelreich
- Gemcitabine Recruits M2-Type Tumor-Associated Macrophages into the Stroma of Pancreatic Cancer(2020)
Authors: Jeroen Dekervel, David Nittner, Louis Libbrecht, Stéphane Plaisance, Baki Topal, An Coosemans, Diether Lambrechts, Eric Van Cutsem, Chris Verslype, Jos van Pelt
- Opposite Macrophage Polarization in Different Subsets of Ovarian Cancer: Observation from a Pilot Study(2020)
Authors: Ann Vankerckhoven, Roxanne Wouters, Jolien Ceusters, Thaïs Baert, Holger Gerhardt, Ignace Vergote, An Coosemans
- Circulating Transcripts and Biomarkers in Uterine Tumors: Is There a Predictive Role?(2020)
Authors: Christine De Bruyn, Thaïs Baert, Thierry Van den Bosch, An Coosemans
- Ultrasonography and translational research in preoperative diagnosis and differentiation of adnexal lesions(2019)
Authors: Chiara Landolfo, Dirk Timmerman, Ben Van Calster, An Coosemans
- Trial watch: dendritic cell vaccination for cancer immunotherapy(2019)
Authors: Jenny Sprooten, Jolien Ceusters, An Coosemans, Patrizia Agostinis, Steven De Vleeschouwer, Abhishek Garg
- Myeloid-derived suppressor cells at diagnosis may discriminate between benign and malignant ovarian tumors(2019)
Authors: An Coosemans, Thaïs Baert, Jolien Ceusters, Pieter Busschaert, Chiara Landolfo, Anne-Sophie Van Rompuy, Wouter Froyman, Patrick Neven, Ben Van Calster, Ignace Vergote, et al.
Pages: 1381 - 1388 - Increased Immunosuppression Is Related to Increased Amounts of Ascites and Inferior Prognosis in Ovarian Cancer(2019)
Authors: An Coosemans, Thaïs Baert, Roxanne Wouters, Jolien Ceusters, Annouschka Laenen, Vincent Vandecaveye, Ignace Vergote
Pages: 5953 - 5962 - Immune-driven therapeutic combinations in a new mouse model of high-grade glioma(2019)
Authors: Matteo Riva, An Coosemans, Marc Van Ranst
Patents
1 - 4 of 4
Linked dataset
1 - 1 of 1